nSTRIDE autologous protein solution (APS) is a novel treatment for joint pain and osteoarthritis (OA) which has been approved by Health Canada and the FDA for treatment of knee OA.
The treatment involves a single injection of a protein liquid derived from your own blood. It’s drawn from an arm vein prior to the injection and centrifuged to remove unwanted blood components and then spun again to obtain the protein liquid. APS has proven to be a safe and effective treatment, which has been shown to reduce pain and protect cartilage by reducing further destruction. As a result, there is a decrease in pain and an improvement in joint function, often within a few weeks of the injection. In clinical studies, patients reported little or no pain in 85% of cases after the procedure and about 70% symptom improvement even 24 months after the treatment.
This treatment has been evaluated most extensively in the knee and is most effective in treatment of mild-moderate OA. For best results, we recommend a single injection. There is a fee for this treatment.
We advise a single APS treatment for $1,250. This price includes a preparation kit, the cost of which is set by the manufacturer (Zimmer Biomet).
Please ensure that you bring your requisition with you to your appointment.